Concepts (127)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Urinary Bladder Neoplasms | 7 | 2025 | 105 | 4.570 |
Why?
|
| Robotic Surgical Procedures | 5 | 2023 | 161 | 2.730 |
Why?
|
| Cystectomy | 5 | 2025 | 35 | 2.390 |
Why?
|
| Prostatic Neoplasms | 4 | 2022 | 418 | 2.170 |
Why?
|
| Urinary Diversion | 3 | 2025 | 12 | 1.900 |
Why?
|
| Laparoscopy | 4 | 2021 | 492 | 1.810 |
Why?
|
| Quality of Life | 7 | 2025 | 1229 | 1.680 |
Why?
|
| Urinary Incontinence | 2 | 2022 | 44 | 1.430 |
Why?
|
| Prostatectomy | 2 | 2021 | 99 | 1.370 |
Why?
|
| Urology | 2 | 2017 | 45 | 0.990 |
Why?
|
| Kidney Neoplasms | 4 | 2023 | 160 | 0.940 |
Why?
|
| Education, Medical, Graduate | 2 | 2017 | 352 | 0.840 |
Why?
|
| Prostate-Specific Antigen | 2 | 2021 | 76 | 0.830 |
Why?
|
| Sexual and Gender Minorities | 1 | 2023 | 76 | 0.740 |
Why?
|
| Postoperative Complications | 3 | 2023 | 1308 | 0.680 |
Why?
|
| Diagnostic Techniques, Urological | 1 | 2020 | 4 | 0.670 |
Why?
|
| Urodynamics | 1 | 2020 | 13 | 0.660 |
Why?
|
| Urinary Incontinence, Stress | 1 | 2020 | 25 | 0.650 |
Why?
|
| Urologic Surgical Procedures | 1 | 2020 | 44 | 0.650 |
Why?
|
| Suburethral Slings | 1 | 2020 | 21 | 0.650 |
Why?
|
| Ureteral Neoplasms | 1 | 2018 | 8 | 0.580 |
Why?
|
| Proctoscopy | 1 | 2017 | 2 | 0.560 |
Why?
|
| Carcinoma, Transitional Cell | 1 | 2018 | 43 | 0.560 |
Why?
|
| Digital Rectal Examination | 1 | 2017 | 2 | 0.560 |
Why?
|
| Prostatic Diseases | 1 | 2017 | 9 | 0.560 |
Why?
|
| Prostate | 3 | 2021 | 90 | 0.530 |
Why?
|
| Early Detection of Cancer | 1 | 2020 | 322 | 0.530 |
Why?
|
| Erdheim-Chester Disease | 1 | 2016 | 2 | 0.520 |
Why?
|
| Humans | 24 | 2025 | 63445 | 0.510 |
Why?
|
| Simulation Training | 1 | 2016 | 65 | 0.460 |
Why?
|
| Breast Neoplasms | 2 | 2021 | 1198 | 0.460 |
Why?
|
| Kidney Diseases | 1 | 2016 | 176 | 0.460 |
Why?
|
| Male | 12 | 2025 | 29891 | 0.450 |
Why?
|
| Carcinoma, Renal Cell | 3 | 2023 | 103 | 0.450 |
Why?
|
| Anus, Imperforate | 1 | 2014 | 3 | 0.430 |
Why?
|
| Urinary Bladder Fistula | 1 | 2013 | 2 | 0.430 |
Why?
|
| Diverticulum, Colon | 1 | 2013 | 4 | 0.430 |
Why?
|
| Scoliosis | 1 | 2014 | 10 | 0.430 |
Why?
|
| Urogenital Abnormalities | 1 | 2014 | 12 | 0.430 |
Why?
|
| Hernia, Umbilical | 1 | 2014 | 7 | 0.430 |
Why?
|
| Sigmoid Diseases | 1 | 2013 | 6 | 0.420 |
Why?
|
| Intestinal Fistula | 1 | 2013 | 10 | 0.420 |
Why?
|
| Prenatal Diagnosis | 1 | 2014 | 40 | 0.410 |
Why?
|
| Foreign Bodies | 1 | 2013 | 55 | 0.400 |
Why?
|
| Prospective Studies | 4 | 2025 | 3293 | 0.390 |
Why?
|
| Curriculum | 1 | 2016 | 599 | 0.370 |
Why?
|
| Aged | 8 | 2025 | 14447 | 0.350 |
Why?
|
| Adenoma, Oxyphilic | 2 | 2019 | 11 | 0.300 |
Why?
|
| Female | 10 | 2025 | 32880 | 0.270 |
Why?
|
| Body Image | 1 | 2025 | 31 | 0.230 |
Why?
|
| Lower Urinary Tract Symptoms | 1 | 2025 | 8 | 0.230 |
Why?
|
| Middle Aged | 5 | 2025 | 17613 | 0.220 |
Why?
|
| Treatment Outcome | 3 | 2023 | 5680 | 0.210 |
Why?
|
| Homosexuality, Male | 1 | 2023 | 38 | 0.200 |
Why?
|
| Urinary Bladder | 1 | 2023 | 45 | 0.200 |
Why?
|
| Sex Factors | 1 | 2025 | 978 | 0.190 |
Why?
|
| Urination | 1 | 2022 | 13 | 0.190 |
Why?
|
| Patient Reported Outcome Measures | 1 | 2023 | 153 | 0.190 |
Why?
|
| Sexual Behavior | 1 | 2023 | 194 | 0.190 |
Why?
|
| Nephrectomy | 2 | 2019 | 91 | 0.190 |
Why?
|
| Neoplasm Grading | 1 | 2021 | 92 | 0.180 |
Why?
|
| Retrospective Studies | 3 | 2023 | 6658 | 0.180 |
Why?
|
| Family Health | 1 | 2021 | 69 | 0.180 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2023 | 131 | 0.180 |
Why?
|
| Surveys and Questionnaires | 2 | 2022 | 2681 | 0.180 |
Why?
|
| Catheter Ablation | 1 | 2023 | 153 | 0.180 |
Why?
|
| Cystitis, Interstitial | 1 | 2020 | 5 | 0.160 |
Why?
|
| Angiomyolipoma | 1 | 2019 | 2 | 0.160 |
Why?
|
| Preventive Health Services | 1 | 2020 | 75 | 0.160 |
Why?
|
| Pain | 1 | 2023 | 406 | 0.160 |
Why?
|
| Watchful Waiting | 1 | 2019 | 29 | 0.160 |
Why?
|
| Ablation Techniques | 1 | 2019 | 24 | 0.160 |
Why?
|
| Tomography, X-Ray Computed | 3 | 2017 | 1644 | 0.150 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2023 | 772 | 0.150 |
Why?
|
| Hospital Charges | 1 | 2018 | 23 | 0.150 |
Why?
|
| Clinical Decision-Making | 1 | 2019 | 165 | 0.150 |
Why?
|
| SEER Program | 1 | 2018 | 74 | 0.140 |
Why?
|
| Lymphatic Metastasis | 1 | 2018 | 88 | 0.140 |
Why?
|
| Efficiency | 1 | 2017 | 41 | 0.140 |
Why?
|
| Neoplasms, Multiple Primary | 1 | 2017 | 32 | 0.130 |
Why?
|
| Delphi Technique | 1 | 2017 | 101 | 0.130 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2018 | 422 | 0.130 |
Why?
|
| Regression Analysis | 1 | 2017 | 498 | 0.130 |
Why?
|
| Equipment Design | 1 | 2017 | 352 | 0.130 |
Why?
|
| Severity of Illness Index | 1 | 2021 | 1553 | 0.130 |
Why?
|
| Proportional Hazards Models | 1 | 2018 | 730 | 0.130 |
Why?
|
| Practice Guidelines as Topic | 1 | 2020 | 724 | 0.120 |
Why?
|
| Survival Rate | 1 | 2018 | 851 | 0.120 |
Why?
|
| United States | 2 | 2020 | 7843 | 0.120 |
Why?
|
| Length of Stay | 1 | 2018 | 812 | 0.110 |
Why?
|
| Risk Assessment | 1 | 2021 | 2079 | 0.110 |
Why?
|
| Cloaca | 1 | 2014 | 1 | 0.110 |
Why?
|
| Adenocarcinoma | 1 | 2017 | 348 | 0.110 |
Why?
|
| Patient Readmission | 1 | 2018 | 429 | 0.110 |
Why?
|
| Time Factors | 1 | 2021 | 3768 | 0.110 |
Why?
|
| Ultrasonography, Prenatal | 1 | 2014 | 44 | 0.100 |
Why?
|
| Computer Simulation | 1 | 2016 | 477 | 0.100 |
Why?
|
| Colonoscopy | 1 | 2013 | 100 | 0.100 |
Why?
|
| Reproducibility of Results | 1 | 2017 | 1654 | 0.100 |
Why?
|
| Clinical Competence | 1 | 2017 | 727 | 0.100 |
Why?
|
| Opioid-Related Disorders | 1 | 2020 | 507 | 0.100 |
Why?
|
| Risk Factors | 1 | 2021 | 5354 | 0.090 |
Why?
|
| Adult | 2 | 2020 | 16824 | 0.080 |
Why?
|
| Infant, Newborn | 1 | 2014 | 1358 | 0.080 |
Why?
|
| Image-Guided Biopsy | 2 | 2019 | 43 | 0.070 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2017 | 2175 | 0.070 |
Why?
|
| Aged, 80 and over | 1 | 2018 | 5462 | 0.070 |
Why?
|
| Internship and Residency | 1 | 2016 | 808 | 0.070 |
Why?
|
| Administration, Intravesical | 1 | 2025 | 13 | 0.060 |
Why?
|
| Botulinum Toxins, Type A | 1 | 2025 | 19 | 0.060 |
Why?
|
| BCG Vaccine | 1 | 2025 | 49 | 0.060 |
Why?
|
| Neoplasm Invasiveness | 1 | 2025 | 278 | 0.050 |
Why?
|
| Microwaves | 1 | 2023 | 14 | 0.050 |
Why?
|
| Recurrence | 1 | 2023 | 641 | 0.040 |
Why?
|
| Nephrons | 1 | 2019 | 7 | 0.040 |
Why?
|
| Organ Sparing Treatments | 1 | 2019 | 16 | 0.040 |
Why?
|
| Biopsy, Large-Core Needle | 1 | 2019 | 20 | 0.040 |
Why?
|
| Longitudinal Studies | 1 | 2023 | 1256 | 0.040 |
Why?
|
| Drug Prescriptions | 1 | 2020 | 168 | 0.040 |
Why?
|
| Smoking | 1 | 2023 | 866 | 0.030 |
Why?
|
| Ultrasonography, Doppler | 1 | 2017 | 27 | 0.030 |
Why?
|
| Mastectomy | 1 | 2017 | 58 | 0.030 |
Why?
|
| Patient Care Team | 1 | 2019 | 338 | 0.030 |
Why?
|
| Positron-Emission Tomography | 1 | 2017 | 208 | 0.030 |
Why?
|
| Analgesics, Opioid | 1 | 2020 | 536 | 0.030 |
Why?
|
| Diagnosis, Differential | 1 | 2017 | 978 | 0.030 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2020 | 712 | 0.030 |
Why?
|